Abstract
.Significance: Most cases of high-grade serous ovarian carcinoma originate as serous tubal intraepithelial carcinoma (STIC) lesions in the fallopian tube epithelium (FTE), enabling early endoscopic detection.Aim: The cell-acquiring fallopian endoscope (CAFE) was built to meet requirements for locating potentially pathological tissue indicated by an alteration in autofluorescence or presence of a targeted fluorophore. A channel was included for directed scrape biopsy of cells from regions of interest.Approach: Imaging resolution and fluorescence sensitivity were measured using a standard resolution target and fluorescence standards, respectively. A prototype was tested in ex vivo tissue, and collected cells were counted and processed.Results: Measured imaging resolution was at a 5-mm distance, and full field of view was in air. Reflectance and fluorescence images in ex vivo porcine reproductive tracts were captured, and fit through human tracts was verified. Hemocytometry counts showed that on the order of per scrape biopsy could be collected from ex vivo porcine tissue.Conclusions: All requirements for viewing STIC in the FTE were met, and collected cell counts exceeded input requirements for relevant analyses. Our benchtop findings suggest the potential utility of the CAFE device for in vivo imaging and cell collection in future clinical trials.
Highlights
Mounting evidence suggests that most cases of high-grade serous ovarian carcinoma originate as serous tubal intraepithelial carcinoma (STIC) lesions in the fallopian tube epithelium (FTE), rather than lesions in the ovarian surface epithelium.[17,18,19,20]
These findings suggest that a device capable of detecting STIC lesions in the fallopian tubes may enable early stage detection of ovarian cancer
We describe the design and construction of our falloposcope based on clinical requirements for detecting STIC, detail the experimental testing of the optical imaging and cell collection subsystems, and summarize the results, which demonstrate that the device is capable of capturing images of adequate resolution for detecting STIC, as well as collecting a sufficient number of cells from the FTE for relevant downstream analyses and diagnosis
Summary
1.1 Origin and Characteristics of Early Stage Ovarian CancerDue to nonspecific clinical symptoms and a lack of effective screening methods, it is exceedingly difficult to diagnose ovarian carcinoma in its early stages.[1,2] Because of the low sensitivity and/or positive predictive value of bimanual ovarian palpation, carbohydrate antigen 125 (CA125) blood tests, and transvaginal ultrasound, even when performed in combination, screening for ovarian cancer can require invasive surgery and removal of the ovaries to make a definitive diagnosis.[3,4,5,6,7] As a result, 79% of cases are not discovered until they are already at an advanced stage when five-year survival rates are as low as 29%.1,8,9 A large number of risk factors for developing epithelial ovarian cancers have been identified, including a family or personal history of breast or ovarian cancer, gene alterations (e.g., BRCA1/2), reproductive history, and advanced age.[8,10,11,12,13] Patients at known risk may be counseled to undergo a prophylactic bilateral salpingooophorectomy, which reduces ovarian cancer risk by up to 81%, but results in immediate onset symptoms of postmenopause and infertility for premenopausal patients, as well as an increased risk of osteoporosis and cardiovascular mortality long-term.[14,15,16]Mounting evidence suggests that most cases of high-grade serous ovarian carcinoma originate as serous tubal intraepithelial carcinoma (STIC) lesions in the fallopian tube epithelium (FTE), rather than lesions in the ovarian surface epithelium.[17,18,19,20] STIC lesions, whether invasive or noninvasive, may spread through exfoliation onto the surface of the ovary or into the peritoneal cavity.[21]. Due to nonspecific clinical symptoms and a lack of effective screening methods, it is exceedingly difficult to diagnose ovarian carcinoma in its early stages.[1,2] Because of the low sensitivity and/or positive predictive value of bimanual ovarian palpation, carbohydrate antigen 125 (CA125) blood tests, and transvaginal ultrasound, even when performed in combination, screening for ovarian cancer can require invasive surgery and removal of the ovaries to make a definitive diagnosis.[3,4,5,6,7] As a result, 79% of cases are not discovered until they are already at an advanced stage when five-year survival rates are as low as 29%.1,8,9. For cancer caught at this stage in the fallopian tube, five-year survival rates may be 95% or greater, and treatment may require neither radical surgery nor adjuvant chemotherapy.[1,6,21]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
